
Release date: 2024-08-19 17:17:08 Article From: Lucius Laos Recommended: 278
Mitotane is a highly potent antineoplastic drug specifically designed to treat inoperable adrenocortical carcinoma and Cushing syndrome.
There may be a variety of side effects associated with the use of Mitotane, which involve multiple systems, including the kidneys, gastrointestinal tract, nervous system, skin, etc. Here's a closer look at these side effects:
Mitotane may cause renal impairment by interfering with the function of renal tubular epithelial cells, resulting in decreased glomerular filtration rate and decreased tubular resorption. In severe cases, acute kidney failure may occur.
Mitotane can inhibit carbonic anhydrase activity and affect renal excretion of bicarbonate, thereby triggering metabolic acidosis. Symptoms such as deepened and accelerated breathing, dry mouth, etc., may lead to electrolyte imbalances in the long term.
Common gastrointestinal side effects include nausea, vomiting, loss of appetite, and diarrhea. The incidence of these symptoms is high and can seriously affect the patient's quality of life.
Preventing kidney damage from Mitotane requires a comprehensive consideration of many aspects, and here are some specific preventive measures:
Use Mitotane strictly according to your doctor's instructions, and do not adjust the dose or discontinue the drug on your own. The doctor will determine the appropriate medication regimen based on the patient's specific situation, including the dose, time, and route of administration.
Regularly monitor renal function indicators, such as serum creatinine, urea nitrogen, etc., to detect renal impairment in a timely manner. If renal function is abnormal, the doctor should be informed and the treatment plan should be adjusted.
To avoid drug interactions, patients should be aware of the following:
Try to avoid combining with nephrotoxic drugs to reduce double damage to the kidneys. If other drugs are needed, they should be done under the guidance of a doctor.
Mitotane can interact with other medications, affecting its effectiveness or increasing side effects. Patients should inform their doctor of all medications they are taking so that they can assess the risk of drug interactions.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1592025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3992024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1532025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1712025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1532025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1872025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1672025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1622025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: